BiiTS

A medical training company (sold in 2008) that created a novel, injectable drug for the reduction of localized fat from a natural compound. Company was sold in 2008. The product had a $300+ mil clinical turnover as of date. For patenting purposes, a proprietary formulation of a purified synthetic version was developed by a biochemical company for FDA research studies and turned into a new product currently in development.